866-997-4948(US-Canada Toll Free)

Europe Belimumab Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 106 Pages

Notes:
Sales, means the sales volume of Belimumab
Revenue, means the sales value of Belimumab

This report studies sales (consumption) of Belimumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
GlaxoSmithKline
Sandoz
Celltrion
Delenex Therapeutics
Bionovis
Fujifilm Kyowa Kirin Biologics
AryoGen Biopharma
MedImmune
Tsumura

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Belimumab in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on sales, market share and growth rate of Belimumab in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

Europe Belimumab Market Report 2016
1 Belimumab Overview
1.1 Product Overview and Scope of Belimumab
1.2 Classification of Belimumab
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Belimumab
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Belimumab Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Belimumab (2011-2021)
1.5.1 Europe Belimumab Sales and Growth Rate (2011-2021)
1.5.2 Europe Belimumab Revenue and Growth Rate (2011-2021)

2 Europe Belimumab by Manufacturers, Type and Application
2.1 Europe Belimumab Market Competition by Manufacturers
2.1.1 Europe Belimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Belimumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Belimumab (Volume and Value) by Type
2.2.1 Europe Belimumab Sales and Market Share by Type (2011-2016)
2.2.2 Europe Belimumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Belimumab (Volume and Value) by Countries
2.3.1 Europe Belimumab Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Belimumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Belimumab (Volume) by Application

3 Germany Belimumab (Volume, Value and Sales Price)
3.1 Germany Belimumab Sales and Value (2011-2016)
3.1.1 Germany Belimumab Sales and Growth Rate (2011-2016)
3.1.2 Germany Belimumab Revenue and Growth Rate (2011-2016)
3.1.3 Germany Belimumab Sales Price Trend (2011-2016)
3.2 Germany Belimumab Sales and Market Share by Manufacturers
3.3 Germany Belimumab Sales and Market Share by Type
3.4 Germany Belimumab Sales and Market Share by Application

4 France Belimumab (Volume, Value and Sales Price)
4.1 France Belimumab Sales and Value (2011-2016)
4.1.1 France Belimumab Sales and Growth Rate (2011-2016)
4.1.2 France Belimumab Revenue and Growth Rate (2011-2016)
4.1.4 France Belimumab Sales Price Trend (2011-2016)
4.2 France Belimumab Sales and Market Share by Manufacturers
4.3 France Belimumab Sales and Market Share by Type
4.4 France Belimumab Sales and Market Share by Application

5 UK Belimumab (Volume, Value and Sales Price)
5.1 UK Belimumab Sales and Value (2011-2016)
5.1.1 UK Belimumab Sales and Growth Rate (2011-2016)
5.1.2 UK Belimumab Revenue and Growth Rate (2011-2016)
5.1.5 UK Belimumab Sales Price Trend (2011-2016)
5.2 UK Belimumab Sales and Market Share by Manufacturers
5.3 UK Belimumab Sales and Market Share by Type
5.4 UK Belimumab Sales and Market Share by Application

6 Russia Belimumab (Volume, Value and Sales Price)
6.1 Russia Belimumab Sales and Value (2011-2016)
6.1.1 Russia Belimumab Sales and Growth Rate (2011-2016)
6.1.2 Russia Belimumab Revenue and Growth Rate (2011-2016)
6.1.6 Russia Belimumab Sales Price Trend (2011-2016)
6.2 Russia Belimumab Sales and Market Share by Manufacturers
6.3 Russia Belimumab Sales and Market Share by Type
6.4 Russia Belimumab Sales and Market Share by Application

7 Italy Belimumab (Volume, Value and Sales Price)
7.1 Italy Belimumab Sales and Value (2011-2016)
7.1.1 Italy Belimumab Sales and Growth Rate (2011-2016)
7.1.2 Italy Belimumab Revenue and Growth Rate (2011-2016)
7.1.7 Italy Belimumab Sales Price Trend (2011-2016)
7.2 Italy Belimumab Sales and Market Share by Manufacturers
7.3 Italy Belimumab Sales and Market Share by Type
7.4 Italy Belimumab Sales and Market Share by Application

8 Spain Belimumab (Volume, Value and Sales Price)
8.1 Spain Belimumab Sales and Value (2011-2016)
8.1.1 Spain Belimumab Sales and Growth Rate (2011-2016)
8.1.2 Spain Belimumab Revenue and Growth Rate (2011-2016)
8.1.8 Spain Belimumab Sales Price Trend (2011-2016)
8.2 Spain Belimumab Sales and Market Share by Manufacturers
8.3 Spain Belimumab Sales and Market Share by Type
8.4 Spain Belimumab Sales and Market Share by Application

9 Benelux Belimumab (Volume, Value and Sales Price)
9.1 Benelux Belimumab Sales and Value (2011-2016)
9.1.1 Benelux Belimumab Sales and Growth Rate (2011-2016)
9.1.2 Benelux Belimumab Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Belimumab Sales Price Trend (2011-2016)
9.2 Benelux Belimumab Sales and Market Share by Manufacturers
9.3 Benelux Belimumab Sales and Market Share by Type
9.4 Benelux Belimumab Sales and Market Share by Application

10 Europe Belimumab Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Belimumab Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Pfizer Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Belimumab Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Sandoz
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Belimumab Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Sandoz Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Celltrion
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Belimumab Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Celltrion Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Delenex Therapeutics
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Belimumab Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Delenex Therapeutics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Bionovis
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Belimumab Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Bionovis Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Fujifilm Kyowa Kirin Biologics
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Belimumab Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Fujifilm Kyowa Kirin Biologics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 AryoGen Biopharma
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Belimumab Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 AryoGen Biopharma Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 MedImmune
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Belimumab Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 MedImmune Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Tsumura
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Belimumab Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Tsumura Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview

11 Belimumab Manufacturing Cost Analysis
11.1 Belimumab Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Belimumab

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Belimumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Belimumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Belimumab Market Forecast (2016-2021)
14.1 Germany Belimumab Sales Forecast (2016-2021)
14.2 France Belimumab Sales Forecast (2016-2021)
14.3 UK Belimumab Sales Forecast (2016-2021)
14.4 Russia Belimumab Sales Forecast (2016-2021)
14.5 Italy Belimumab Sales Forecast (2016-2021)
14.6 Spain Belimumab Sales Forecast (2016-2021)
14.7 Benelux Belimumab Sales Forecast (2016-2021)
14.8 Europe Belimumab Sales Forecast by Type (2016-2021)
14.9 Europe Belimumab Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer


List of Table

List of Tables and Figures

Figure Picture of Belimumab
Table Classification of Belimumab
Figure Europe Sales Market Share of Belimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Belimumab
Figure Europe Sales Market Share of Belimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Belimumab Revenue and Growth Rate (2011-2021)
Figure France Belimumab Revenue and Growth Rate (2011-2021)
Figure UK Belimumab Revenue and Growth Rate (2011-2021)
Figure Russia Belimumab Revenue and Growth Rate (2011-2021)
Figure Italy Belimumab Revenue and Growth Rate (2011-2021)
Figure Spain Belimumab Revenue and Growth Rate (2011-2021)
Figure Benelux Belimumab Revenue and Growth Rate (2011-2021)
Figure Europe Belimumab Sales and Growth Rate (2011-2021)
Figure Europe Belimumab Revenue and Growth Rate (2011-2021)
Table Europe Belimumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Belimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Belimumab Sales Share by Manufacturers
Figure 2016 Belimumab Sales Share by Manufacturers
Table Europe Belimumab Revenue by Manufacturers (2015 and 2016)
Table Europe Belimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Belimumab Revenue Share by Manufacturers
Table 2016 Europe Belimumab Revenue Share by Manufacturers
Table Europe Belimumab Sales and Market Share by Type (2011-2016)
Table Europe Belimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Belimumab by Type (2011-2016)
Figure Europe Belimumab Sales Growth Rate by Type (2011-2016)
Table Europe Belimumab Revenue and Market Share by Type (2011-2016)
Table Europe Belimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Belimumab by Type (2011-2016)
Figure Europe Belimumab Revenue Growth Rate by Type (2011-2016)
Table Europe Belimumab Sales and Market Share by Countries (2011-2016)
Table Europe Belimumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Belimumab by Countries (2011-2016)
Table Europe Belimumab Revenue and Market Share by Countries (2011-2016)
Table Europe Belimumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Belimumab by Countries (2011-2016)
Table Europe Belimumab Sales and Market Share by Application (2011-2016)
Table Europe Belimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Belimumab by Application (2011-2016)
Figure Germany Belimumab Sales and Growth Rate (2011-2016)
Figure Germany Belimumab Revenue and Growth Rate (2011-2016)
Figure Germany Belimumab Sales Price Trend (2011-2016)
Table Germany Belimumab Sales by Manufacturers (2015 and 2016)
Table Germany Belimumab Market Share by Manufacturers (2015 and 2016)
Table Germany Belimumab Sales by Type (2015 and 2016)
Table Germany Belimumab Market Share by Type (2015 and 2016)
Table Germany Belimumab Sales by Application (2015 and 2016)
Table Germany Belimumab Market Share by Application (2015 and 2016)
Figure France Belimumab Sales and Growth Rate (2011-2016)
Figure France Belimumab Revenue and Growth Rate (2011-2016)
Figure France Belimumab Sales Price Trend (2011-2016)
Table France Belimumab Sales by Manufacturers (2015 and 2016)
Table France Belimumab Market Share by Manufacturers (2015 and 2016)
Table France Belimumab Sales by Type (2015 and 2016)
Table France Belimumab Market Share by Type (2015 and 2016)
Table France Belimumab Sales by Application (2015 and 2016)
Table France Belimumab Market Share by Application (2015 and 2016)
Figure UK Belimumab Sales and Growth Rate (2011-2016)
Figure UK Belimumab Revenue and Growth Rate (2011-2016)
Figure UK Belimumab Sales Price Trend (2011-2016)
Table UK Belimumab Sales by Manufacturers (2015 and 2016)
Table UK Belimumab Market Share by Manufacturers (2015 and 2016)
Table UK Belimumab Sales by Type (2015 and 2016)
Table UK Belimumab Market Share by Type (2015 and 2016)
Table UK Belimumab Sales by Application (2015 and 2016)
Table UK Belimumab Market Share by Application (2015 and 2016)
Figure Russia Belimumab Sales and Growth Rate (2011-2016)
Figure Russia Belimumab Revenue and Growth Rate (2011-2016)
Figure Russia Belimumab Sales Price Trend (2011-2016)
Table Russia Belimumab Sales by Manufacturers (2015 and 2016)
Table Russia Belimumab Market Share by Manufacturers (2015 and 2016)
Table Russia Belimumab Sales by Type (2015 and 2016)
Table Russia Belimumab Market Share by Type (2015 and 2016)
Table Russia Belimumab Sales by Application (2015 and 2016)
Table Russia Belimumab Market Share by Application (2015 and 2016)
Figure Italy Belimumab Sales and Growth Rate (2011-2016)
Figure Italy Belimumab Revenue and Growth Rate (2011-2016)
Figure Italy Belimumab Sales Price Trend (2011-2016)
Table Italy Belimumab Sales by Manufacturers (2015 and 2016)
Table Italy Belimumab Market Share by Manufacturers (2015 and 2016)
Table Italy Belimumab Sales by Type (2015 and 2016)
Table Italy Belimumab Market Share by Type (2015 and 2016)
Table Italy Belimumab Sales by Application (2015 and 2016)
Table Italy Belimumab Market Share by Application (2015 and 2016)
Figure Spain Belimumab Sales and Growth Rate (2011-2016)
Figure Spain Belimumab Revenue and Growth Rate (2011-2016)
Figure Spain Belimumab Sales Price Trend (2011-2016)
Table Spain Belimumab Sales by Manufacturers (2015 and 2016)
Table Spain Belimumab Market Share by Manufacturers (2015 and 2016)
Table Spain Belimumab Sales by Type (2015 and 2016)
Table Spain Belimumab Market Share by Type (2015 and 2016)
Table Spain Belimumab Sales by Application (2015 and 2016)
Table Spain Belimumab Market Share by Application (2015 and 2016)
Figure Benelux Belimumab Sales and Growth Rate (2011-2016)
Figure Benelux Belimumab Revenue and Growth Rate (2011-2016)
Figure Benelux Belimumab Sales Price Trend (2011-2016)
Table Benelux Belimumab Sales by Manufacturers (2015 and 2016)
Table Benelux Belimumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Belimumab Sales by Type (2015 and 2016)
Table Benelux Belimumab Market Share by Type (2015 and 2016)
Table Benelux Belimumab Sales by Application (2015 and 2016)
Table Benelux Belimumab Market Share by Application (2015 and 2016)
Table Belimumab Basic Information List
Table Pfizer Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Belimumab Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Belimumab Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Belimumab Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Belimumab Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Belimumab Sales Market Share (2011-2016)
Table Bionovis Basic Information List
Table Bionovis Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionovis Belimumab Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Belimumab Sales Market Share (2011-2016)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table AryoGen Biopharma Belimumab Sales Market Share (2011-2016)
Table MedImmune Basic Information List
Table MedImmune Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune Belimumab Sales Market Share (2011-2016)
Table Tsumura Basic Information List
Table Tsumura Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tsumura Belimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Belimumab
Figure Manufacturing Process Analysis of Belimumab
Figure Belimumab Industrial Chain Analysis
Table Raw Materials Sources of Belimumab Major Manufacturers in 2015
Table Major Buyers of Belimumab
Table Distributors/Traders List
Figure Germany Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure France Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Belimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Belimumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Belimumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Belimumab Sales Forecast by Type (2016-2021)
Table Europe Belimumab Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *